Downregulation of phosphoserine phosphatase potentiates tumor immune environments to enhance immune checkpoint blockade therapy
Background Effects of immune checkpoint blockade (ICB) treatment in hepatocellular carcinoma (HCC) are limited. The current study explored the possibility of exploiting tumor metabolic switches to enhance HCC sensitivity to immune therapies.Methods Levels of one-carbon (1C) metabolism and the expres...
Main Authors: | Yan Wu, Da Jiang, Zhi-Peng Peng, Xing-Chen Liu, Yong-Hao Ruan, Ai-Qi Huang, Wan-Ru Ning, Ze-Zhou Jiang, Limin Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-02-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/2/e005986.full |
Similar Items
-
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
by: Douglas B. Fox, et al.
Published: (2023-03-01) -
Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer
by: Mei Feng, et al.
Published: (2023-06-01) -
MTHFR act as a potential cancer biomarker in immune checkpoints blockades, heterogeneity, tumor microenvironment and immune infiltration
by: Jianheng Peng, et al.
Published: (2023-06-01) -
A Novel Assay for Phosphoserine Phosphatase Exploiting Serine Acetyltransferase as the Coupling Enzyme
by: Francesco Marchesani, et al.
Published: (2021-05-01) -
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
by: Crismita Dmello, et al.
Published: (2023-03-01)